Metrological traceability in flow cytometry? Evaluation of a new volumetric method for lymphocyte subsets

Abstract

AbstractIntroductionLymphocyte subset enumeration by flow cytometry is important for the therapeutic monitoring of a range of conditions. However, current bead‐based methodologies do not produce metrologically traceable results. Here we compare an established bead‐based methodology with a volumetric‐based system traceable to an internationally recognised reference method.MethodA total of 118 samples received for lymphocyte subset analysis were tested using an established bead‐based technique (BD Multitest™ 6‐colour TBNK assay using Trucount™ tubes on a BD FACSLyric flow cytometer), followed by a volumetric method on the Sysmex XF‐1600 flow cytometer using Exbio Kombitest 6‐colour TBNK reagent. All samples were tested in accordance with the manufacturer's instructions.ResultsAbsolute count values from both methodologies for CD3+, CD3 + CD4+, CD3 + CD8+, CD19+ and CD3‐CD16+/CD56+ lymphocyte populations were compared using linear regression (R2 for all parameters >0.95) and Bland–Altman analysis. There was no significant bias (where p < 0.05) for absolute CD3 + CD4+ lymphocytes in the defined therapeutic range of 0–250 cells/μL (mean bias: 0.27 cells/μL). Although positive biases were seen for CD3 + CD4+ lymphocytes (over the entire range tested: 14–1798 cells/μL) and CD3‐CD16+/CD56+ lymphocytes (mean bias: 10.83 cells/μL and 6.79 cells/μL, respectively). Negative biases were seen for CD3 + CD8+ and CD19+ lymphocytes (mean bias: −29.17 cells/μL and − 18.76 cells/μL, respectively).ConclusionA high degree of correlation was found for results from both methodologies and observed bias was within the limits of clinical acceptability for all populations. This shows that the metrologically traceable lymphocyte subset absolute counts produced by the Sysmex XF‐1600 are robust within clinically required limits.